Physiological Validation of Current Machine Learning Models for Hemodynamic Instability in Humans
1 other identifier
interventional
100
1 country
1
Brief Summary
This study will be collecting data on participants undergoing lower body negative pressure (LBNP) to simulate progressive blood loss. The goal of the study is to collect data to allow for development of an algorithm with machine learning to predict blood pressure responses to hyporvolemia by analyzing the arterial waveforms collected during LBNP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2019
CompletedFirst Posted
Study publicly available on registry
April 25, 2019
CompletedStudy Start
First participant enrolled
May 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2022
CompletedMay 31, 2023
May 1, 2023
1.5 years
April 22, 2019
May 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Blood Pressure
Arterial blood pressure both systolic and diastolic will be assessed prior to and during lower body negative pressure
One day of study visit
Secondary Outcomes (1)
Heart rate
One day of study visit
Study Arms (1)
Healthy Volunteer
EXPERIMENTALAll Volunteers will be studied at rest and during experimental condition (lower body negative pressure)
Interventions
Simulated hypovolemia by applied suction to lower extremities to cause venous pooling.
Eligibility Criteria
You may qualify if:
- Non-obese (BMI \< 30)
- Non-smokers
- Free of any systemic diseases including hypertension, diabetes, coronary artery disease, neurologic disease, or any other major medical co-morbidity
- Women will be either surgically sterilized or non-pregnant as determined by a urine pregnancy test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timothy B Curry
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 22, 2019
First Posted
April 25, 2019
Study Start
May 12, 2021
Primary Completion
November 8, 2022
Study Completion
November 8, 2022
Last Updated
May 31, 2023
Record last verified: 2023-05